Breaking News

MedRhythms Selects Curavit for MR-001 Trial in Stroke Impairment

Curavit is responsible for managing all aspects of MedRhythms’ hybrid decentralized clinical trial.

Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) for digital therapeutics (DTx), was selected for a study of MR-001, MedRhythms’ neurorehabilitation system designed to improve walking and ambulation in adults with chronic stroke walking impairment. The goal of the study is to further characterize the long-term clinical benefits of MR-001 beyond what has been established in a multi-center, randomized clinical trial...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters